Jeremy Allred

Dr. Jeremy Allred serves as an Assistant Professor of Medicine within the Division of Hematology, Oncology, and Transplantation at the University of Minnesota School of Medicine. His clinical and research activities focus on advancing therapeutic strategies for hematologic malignancies and improving outcomes in stem cell transplantation, with particular emphasis on translational applications of cellular therapies and immune modulation.

Dr. Allred's research program centers on acute myeloid leukemia (especially TP53-mutated subtypes), graft-versus-host disease mechanisms, and innovative immunotherapies including CAR T-cell treatments. His work investigates genetic determinants of treatment response, strategies to mitigate therapy-related toxicities like neurotoxicity, and the application of induced pluripotent stem cell technologies for immune cell generation. Key interests include VISTA immune checkpoint biology, sarcopenia assessment in transplant recipients, and optimizing salvage therapies for high-risk leukemia patients.

Analysis of Dr. Allred's publication record (2015-2025) reveals a consistent trajectory in translational hematology/oncology research with growing emphasis on cellular therapies and immune regulation. His recent work demonstrates increasing focus on TP53-mutated AML therapeutics, GVHD prevention through novel immune checkpoints, and practical management of CAR T-cell complications. The publications collectively show progression from basic hematopoiesis mechanisms toward clinically applicable interventions in transplantation and immunotherapy, with significant contributions to understanding treatment sequencing in secondary leukemias and stem cell-derived immune cell engineering.